ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine
February 03, 2021Kira Pharmaceuticals announced that the first healthy volunteer has been successfully dosed in a first-in-human Phase 1 clinical trial for its lead investigational therapy P014. This randomized, double blind, placebo-controlled study will evaluate the ...
Pharma Sources Insight January 2025
